Researchers at the Technical University of Munich (TUM) have developed a system that helps patients learn to move their ...

Wearable exoskeletons show potential in reducing work-related back injuries by decreasing perceived exertion and increasing productivity by approximately 6% during physically demanding tasks.

Lifeward announced today that it received FDA 510(k) clearance for its latest-generation personal exoskeleton device, ReWalk ...

Leading Exoskeleton Includes New and Enhanced Features for Individuals with Spinal Cord InjuryMARLBOROUGH, Mass. and YOKNEAM ...

The FDA clearance marks a significant milestone for Lifeward, reinforcing its leadership in the medical exoskeleton market. With prior regulatory and reimbursement wins, the launch of ReWalk 7 ...

FDA clearance for the newest generation of its personal exoskeleton device, the ReWalk 7. The seventh generation of the ReWalk, a wearable exoskeleton that allows individuals with spinal cord injury ...

FRIDAY, March 14, 2025 (HealthDay News) -- A muscle-stimulating implant combined with a robotic exoskeleton can help restore ...

The ReWalk Exoskeleton is the only personal exoskeleton that offers ... including mobility equipment, medical supplies, and home health care. Our commitment to fostering strategic partnerships allows ...

The Company made history in 2014 when it received the nation’s first FDA clearance for an exoskeleton medical device for individuals with SCI. Lifeward will begin sales of the ReWalk 7 in the ...